Avid Bioservices Inc (CDMO)

[pphmtoolong]

Disconnect. That is the word for Peregrine and its share price. While Peregrine is making progress in the pivotal, Phase III Sunrise trial, advancing research in Bavi with MSK, and "partnering" with AstraZeneca, the share price sinks. That is some disconnect.

The good thing about disconnects is that the world hates them. Sooner or later, we hope sooner, the disconnect will be resolved when the share price comes back into connection with Peregrine's reality.

I know this won't happen until the market sees the money. There are several ways this can happen. Lucrative partnerships, buyout, growing distribution network of an approved Bavi.

Who knows when this will happen. Only the last possibility is clearly months away.

GLTA, Especially Bavii-arm Sunrise Patients,

Paul